Denmark: IO Biotech secures up to €57.5 million EIB venture debt to advance cancer vaccine research and development

Parliament calls for continued EU action to fight cancer This article is published in association with European Investment Bank. Danish med-tech company IO Biotech has signed a €57.5 million venture debt deal with the European Investment Bank. The debt facility includes three committed tranches totalling up to €37.5 million, which will become available if the company satisfies certain conditions, and one uncommitted accordion tranche of […]
Go back up

The European Sting – Critical News & Insights on European Politics, Economy, Foreign Affairs, Business & Technology – europeansting.com